Stock·NYSE·Consumer Defensive
British American Tobacco (BTI)
- Market cap
- $124.72B
- P/E
- 14.25
- Dividend yield
- 5.61%
- Street target
- $71.50median of 7 analysts
- 52-week range
- $49.88 $67.30
The short version
Where BTI stands today, in four lines, and what CleaRank Financial AI makes of it.
BTI at a glance
British American Tobacco (BTI): Buy, 75/100 on CleaRank's AI score.
- Trend Mixed: the price is above its 50-day but below its 200-day moving average ($55.86 and $58.91).
- Earnings BTI beat estimates in 3 of its last 4 quarters, and the stock rose the next day every time.
- Valuation P/E of 14.3 against 24.2 for the Consumer Defensive sector: a discount to peers (-41%).
Figures as of October 16, 2026.
CleaRank Financial AI
British American Tobacco is currently trading at $58, above its 50-day and 20-day moving averages, indicating positive short-term momentum.
The stock's technical indicators, including a bullish RSI status, suggest continued upward potential. Wall Street analysts maintain a strong buy consensus with a median price target of $71.5, implying a 23.3% upside from the current price. The company's strong dividend yield of approximately 5.6% also adds to its appeal for income-focused investors. Despite a slightly elevated P/E ratio compared to the sector average, British American Tobacco's profitability metrics, such as a 24.99% net profit margin and a 13.42% return on equity, are solid. The company's revenue growth has been modest at 1.4%, but forward estimates suggest a slight acceleration. The primary risk remains the long-term secular decline in tobacco consumption, although the company's diversification efforts and market position provide some resilience.
Only on CleaRank
Figures we compute ourselves from BTI's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
1/4Price above its 50-day average ›
The price of $58.00 is 3.8% above the 50-day simple moving average of $55.86.Price above its 200-day average ›
The price is 1.5% below the 200-day simple moving average of $58.91.50-day average above the 200-day ›
The 50-day average ($55.86) is 5.2% below the 200-day average ($58.91), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 47% of its 52-week range, between $49.88 and $67.30.
BTI share price
Pick a period: each tab shows how far BTI has moved over it, to the last close.
Today's trading
Where BTI sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
4/5P/E below the sector median ›
The trailing P/E of 14.25 is 41.1% below the Consumer Defensive median of 24.2.P/S below the sector median ›
The price-to-sales ratio of 3.65 is 65.8% above the sector median of 2.2.Profitable over the last 12 months ›
Net income over the last 12 months was $8.4B on revenue of $34.2B, a net margin of 24.6%.Beat estimates in most recent reports ›
BTI beat the EPS estimate in 3 of its last 4 reports.Pays a dividend ›
The trailing dividend yield is 5.61%, or $3.25 a share a year.
Key statistics
The headline figures for BTI.
As of October 16, 2026, BTI trades at $58.00, with a market value of $124.72B, a P/E ratio of 14.25 and a dividend yield of 5.61%.
What the numbers say
CleaRank Financial AI's reading of BTI's valuation, growth and risks.
British American Tobacco's P/E ratio of 14.25 is below the sector average of 24.2, suggesting it may be undervalued relative to its peers.
Its price-to-sales ratio of 3.65 is above the sector average of 2.2, indicating a potential premium on its revenue. The company's net profit margin of 24.99% and operating margin of 34.91% are strong, outperforming the sector's median ROE of 19.7%. The company's revenue growth of 1.4% is lower than the sector average of 5.3%, but forward estimates suggest a slight increase. While the current valuation appears attractive on a P/E basis, the higher price-to-sales ratio warrants attention. The strong profitability and dividend yield provide a solid fundamental underpinning.
BTI against the Consumer Defensive sector
How BTI compares with the median Consumer Defensive stock CleaRank tracks.
Price to earnings vs sector: BTI trades at a notable discount to sector peers (-41%), which may indicate undervaluation or specific company headwinds.
Return vs VDC: Since May 5, 2025, BTI has gained 32.6% against a gain of 6.5% for VDC.
Performance against VDC
BTI and the Consumer Defensive sector fund over the same days.
Revenue and earnings
How much BTI sells, and how much of it becomes profit.
Revenue growth: Revenue fell 1.0% in FY2025 to $25.6B, from $25.9B a year earlier.
Profit margin: The net margin was 30.3% in FY2025, up from 12.3% the year before.
Profitable: BTI earned $7.8B in FY2025.
Earnings reality check
Did BTI beat what analysts expected, and how did the stock react?
Earnings record: BTI beat the analyst estimate in 3 of the last 4 quarters.
Market reaction: The stock rose in the first session after every beat.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Oct 26, 2006after close | $0.32 | $0.51 | +59.38% | +1.27% | +2.06% |
| Jul 27, 2006after close | $0.46 | $0.50 | +8.70% | +1.27% | +2.06% |
| May 2, 2006after close | $0.41 | $0.38 | -7.32% | +1.27% | +2.06% |
| Feb 28, 2006after close | $0.32 | $0.40 | +25.00% | +1.27% | +2.06% |
Reports after October 26, 2006 are not yet in our data.
As of October 16, 2026, BTI has beaten the analyst EPS estimate in 3 of its last 4 reported quarters and rose in the first trading session after every one of those beats; its most recent report in our data, on October 26, 2006, came in 59.38% above the estimate and the stock moved +1.27% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
3/3RSI not overbought or oversold ›
The 14-day RSI is 65.8, showing bullish momentum without being overbought.RSI above 50 ›
An RSI of 65.8 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is positive, so the 12-day average is above the 26-day average.
CleaRank AI analysis of BTI
The score, the reasoning behind it, and what could move the price next.
Volume has surged by over 100% compared to its average, signaling strong investor interest in British American Tobacco.
The stock is trading above its 50-day SMA at $55.86 and its 20-day EMA at $55.44, indicating an upward trend. The 14-day RSI is at 65.78, classified as bullish, suggesting continued positive momentum. The MACD is slightly positive at 0.06, hinting at a potential shift towards bullish territory. Key support levels are seen around the 50-day SMA, while resistance may emerge near the 200-day SMA at $58.91. The current price of $58 is just below the 200-day SMA, suggesting a critical juncture for the stock. The CCI is in overbought territory at 173.35, which could signal a short-term pullback, but the overall trend remains positive.
Strong Analyst Consensus and Price Targets ›
Seven Wall Street analysts have initiated or maintained Buy ratings, with a median price target of $71.5, indicating a 23.3% potential upside. This reflects strong institutional confidence in the company's future performance.
Source: Wall Street AnalystsConsistent Earnings Beats ›
Recent earnings reports, such as the one on October 26, 2006, have shown significant EPS surprises (59.38%), suggesting operational efficiency and the ability to exceed market expectations.
Source: Company FilingsAttractive Dividend Yield ›
The company offers a dividend yield of approximately 5.6%, providing a steady income stream and supporting the stock's appeal, especially in a low-interest-rate environment.
Source: Financial Data
Long-Term Secular Decline in Tobacco Consumption ›
Growing health consciousness and stricter regulations worldwide pose a persistent threat to the core tobacco business, potentially impacting long-term revenue and profit growth.
Source: Industry TrendsTrading Near 200-Day Moving Average Resistance ›
The current price of $58 is approaching the 200-day SMA of $58.91, a level that could act as significant resistance and potentially trigger a short-term pullback if not decisively broken.
Source: Technical Analysis
- British American Tobacco offers a compelling dividend yield of approximately 5.6%, making it an attractive option for income-focused portfolios.
- The stock is trading just below its 200-day SMA at $58.91; a decisive move above this level could signal a significant bullish trend reversal.
Technical indicators
Momentum and trend for BTI, from its daily closes.
As of October 16, 2026, with BTI at $58.00, its 14-day RSI is 65.8 (showing bullish momentum without being overbought), its 50-day simple moving average is $55.86 and its 200-day is $58.91.
Calculated by CleaRank on daily closes as of October 16, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What BTI moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 16, 2026, BTI's 1-year correlation of daily returns is +0.06 with S&P 500 (SPY), -0.03 with Nasdaq 100 (QQQ), +0.08 with Bitcoin (BTC) and +0.05 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
3/3Most analysts rate it a buy ›
7 of 7 analysts rate it a buy or strong buy, 0 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $71.50 is 23.3% above the price.More buy ratings than three months ago ›
7 of 7 rate it a buy now, against 5 of 6 three months ago.
BTI Wall Street View
12-month price targets
The price, $58.00, sits below every analyst's target.
Ratings
As of October 16, 2026, 7 Wall Street analysts cover BTI: 7 rate it a buy or strong buy, 0 a hold and 0 a sell or strong sell. Their 12-month price targets range from $63.00 to $75.00, with a median of $71.50, 23.3% above the price of $58.00.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
BTI trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from BTI's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much BTI tends to move, against the market and on its own.
The long record
BTI's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
3/4Average daily move under 2% ›
The price has moved 1.36% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 54.4%, from June 2017 to December 2018, regained by April 2025.Most 1-year holds ended higher ›
61% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $19,110, against $42,525 in the S&P 500 (SPY).
BTI Drawdowns & Recovery
As of October 16, 2026, BTI's worst peak-to-trough fall over the last 10 years with dividends reinvested was -54.4% (June 2017 to December 2018); it regained that peak by April 2025, 76 months after the low, and 61% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into BTI in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: BTI trailed the S&P 500 over this period: $19,110 against $42,525.
A $10,000 investment in BTI in October 2016 would be worth about $19,110 today with dividends reinvested, compared with about $42,525 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to BTI, and which have not.
Strongest month, January: an average of +5.82%, up in 9 of 10 years.
Weakest month, September: an average of -2.00%, up in 3 of 10 years.
This month, October: has averaged -0.67%, up in 3 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, BTI's strongest calendar month has been January (average +5.82%, up in 9 of 10 years) and its weakest September (average -2.00%, up in 3 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in BTI, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in BTI today could grow to about $13,479 by 2036 in the base case, with a 90th-percentile outcome near $36,489 and a 10th-percentile outcome around $4,979. The simulation models price only; at today's 5.61% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
BTI Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $65.36 for BTI by 2030 in the base case, from $58.00 today (1.1x over 4 years). The 10th-percentile path ends near $34.81. These are outcomes of a Monte Carlo simulation run on BTI's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $43.61 | $59.76 | $81.88 | |
| 2028 | $39.44 | $61.57 | $96.11 | |
| 2029 | $36.76 | $63.43 | $109 | |
| 2030 | $34.81 | $65.36 | $123 | |
| 2031 | $33.30 | $67.34 | $136 |
Method: a lognormal simulation of BTI's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
BTI insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Insider buying: No insider bought BTI shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Feb 11, 2026 | Anand (Kandy)
|
Other | 0 | - |
| Feb 11, 2026 | Jobin (Luc)
|
Other | 0 | - |
| Feb 11, 2026 | Kessler (Murray S)
|
Other | 0 | - |
| Feb 11, 2026 | Thomas (Darrell)
|
Other | 0 | - |
| Dec 31, 2025 | Anand (Kandy)
|
Other | 0 | - |
| Dec 31, 2025 | Jobin (Luc)
|
Other | 0 | - |
| Dec 31, 2025 | Kessler (Murray S)
|
Other | 0 | - |
| Dec 31, 2025 | Thomas (Darrell)
|
Other | 0 | - |
| Apr 23, 2025 | Spring Mountain Investments, Ltd.
|
Grant | 5.6M | - |
| Apr 17, 2025 | Spring Mountain Investments, Ltd.
|
Other | 0 | - |
Source: TwelveData, from reported insider filings
Questions people ask
Answered from the figures on this page, as of October 16, 2026.